immune system
• mice treated with MOG35-55, complete Freund's adjuvant (CFA), and pertussis toxin exhibit more severe clinical symptoms (lesions scores, demyelination, suppuration, mononuclear cellular infiltration, blood brain barrier permeability) in the brain and enhanced duration of the acute-early phase compared with similarly treated wild-type mice
• however, mice exhibit normal experimental autoimmune encephalomyelitis in the spinal cord and encephalitogenic T cell response
|
• pertussis toxin-treated mice exhibit longer persistence of HA sensitization than similarly treated wild-type mice
• following treatment with complete Freund's adjuvant (CFA) and pertussis toxin, blood-brain barrier permeability is increased compared to in similarly treated wild-type mice
|
cardiovascular system
• following treatment with MOG35-55, complete Freund's adjuvant (CFA), and pertussis toxin (PTX) or only CFA and PTX, blood-brain barrier permeability is increased compared to in similarly treated wild-type mice
|
homeostasis/metabolism
• following FeCl3 injury, mice exhibit an increased time to clot formation and fail to completely occlude vessels unlike similarly treated wild-type mice
|
nervous system
• following treatment with MOG35-55, complete Freund's adjuvant (CFA), and pertussis toxin (PTX) or only CFA and PTX, blood-brain barrier permeability is increased compared to in similarly treated wild-type mice
|